Non-esterified fatty acids are the molecules released from triglycerides as a result of enzyme lipase action which is then transported in the blood bound to albumin. Management of non-esterified fatty acids level is important in diabetic patients and the levels are also frequently increasing among the obese population. The rising patient pool is likely to drive the non-esterified fatty acid testing and will be furthered propel the growth of non-esterified fatty acid reagent market. The fluctuation of the insulin level and poor diet will adversely affect the release of non-esterified fatty acids in the body which may develop cardiovascular disease. Conditions like diabetes type 2/ insulin resistance, obesity, metabolic syndrome, and malignant diseases all are related to increased non-esterified fatty acids concentrations in the blood. This factor will boost the need for non-esterified fatty acid testing and is likely to contribute to the non-esterified fatty acid reagent market growth. Additionally, from past few years, awareness has been raised among these population group which is likely to contribute to the growth of the non-esterified fatty acid reagent market.
According to the International Diabetes Federation, The diabetic population is expected to rise to 600 Mn by 2045. Around 79% of diabetic adults’ are from low- & middle-income countries. This factor will increase the non-esterified fatty acid testing and is likely to contribute to the non-esterified fatty acid reagent market growth. Healthcare professionals recommend diabetic patients to regularly check body fat which will increase the testing demand and will boost the non-esterified fatty acid reagent market growth. According to the World Health Organization, approximately 1.9 Bn population aged 18 years and above were overweight, in 2016, globally. The increasing obese population is expected to boost the need for non-esterified fatty acid testing and is expected to contribute to the non-esterified fatty acid reagent market growth over the coming years.
To remain ‘ahead’ of your competitors, request for a sample [email protected]
The global market for non-esterified fatty acid reagents segmented on application, sample type, end user, and, geography.
- Non-esterified fatty acid reagents Segmentation by Application
- Lipid Metabolism Disorders
- Malignant Diseases
- Metabolic Syndrome
- Non-esterified fatty acid reagents Segmentation by Sample Type
- Tissue Homogenate
- Cells or Cell Supernatant
- Non-esterified fatty acid reagents Segmentation by End User
- Outpatient Centers
- Specialty Clinics
- Diagnostic Laboratories
A non-esterified fatty acid is produced by the hydrolysis of fats and oils. To detect the level non-esterified fatty acid reagents and assay kits are required. Non-esterified fatty acid reagents are expected to show high revenue growth for the global non-esterified fatty acid reagents market due to the rising ageing population and poor lifestyle especially among adults and young age population. According to the World Health Organization, the prevalence rate of obesity approximately triplicated between 1975 and 2016 worldwide. This factor has increased the non-esterified fatty acid testing and boosted the growth of non-esterified fatty acid reagent market. Moreover, the on-esterified fatty acid reagent market is likely to experience significant growth opportunities in the coming years because of rising patient pool.
To receive extensive list of important regions, Request Methodology here @
The North America non-esterified fatty acid reagents market is expected to be a prominent market and is estimated to show high market growth owing to progressive clinical diagnostic infrastructure and resources in the region. The non-esterified fatty acid reagents market in Europe region is expected to be the lucrative market for non-esterified fatty acid reagents. The non-esterified fatty acid reagents market in the Asia Pacific region is likely to show a high growth due to presence of high market opportunity in the non-esterified fatty acid reagents market. The large number of underserved population is likely to fuel the growth of the non-esterified fatty acid reagents market.
Some of the key players in the non-esterified fatty acid reagents market include Sekisui Diagnostics (Sekisui Chemical), FUJIFILM Wako Diagnostics USA Corporation, Randox Laboratories, Biocompare, Cell Biolabs, Inc., Amsbio LLC (AMS Biotechnology (Europe) Ltd), IGZ Instruments AG, Sigma-Aldrich Corporation, Weldon Biotech India Pvt. Ltd., Instruchemie B.V., Pacific Biomarkers Inc (Neomed-Labs Inc), Cedarlane, Elabscience, and others.
You Can Request for TOC Here @ https://www.persistencemarketresearch.com/toc/30673
Explore Extensive Coverage of PMR`s
Life Sciences & Transformational Health Landscape
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com